DE69130099T2 - Antineoplastischer wirkstoff - Google Patents

Antineoplastischer wirkstoff

Info

Publication number
DE69130099T2
DE69130099T2 DE69130099T DE69130099T DE69130099T2 DE 69130099 T2 DE69130099 T2 DE 69130099T2 DE 69130099 T DE69130099 T DE 69130099T DE 69130099 T DE69130099 T DE 69130099T DE 69130099 T2 DE69130099 T2 DE 69130099T2
Authority
DE
Germany
Prior art keywords
active substance
antineoplastic active
antineoplastic
substance
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69130099T
Other languages
English (en)
Other versions
DE69130099D1 (de
Inventor
Kazuyoshi Kawai
Yasue Konishi
Satoru Nakai
Yoshikatsu Hirai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69130099D1 publication Critical patent/DE69130099D1/de
Publication of DE69130099T2 publication Critical patent/DE69130099T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69130099T 1990-05-09 1991-05-02 Antineoplastischer wirkstoff Expired - Fee Related DE69130099T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2120557A JP2587711B2 (ja) 1990-05-09 1990-05-09 抗腫瘍剤
PCT/JP1991/000601 WO1991016916A1 (en) 1990-05-09 1991-05-02 Antineoplastic agent

Publications (2)

Publication Number Publication Date
DE69130099D1 DE69130099D1 (de) 1998-10-08
DE69130099T2 true DE69130099T2 (de) 1999-02-18

Family

ID=14789258

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130099T Expired - Fee Related DE69130099T2 (de) 1990-05-09 1991-05-02 Antineoplastischer wirkstoff

Country Status (7)

Country Link
EP (1) EP0482213B1 (de)
JP (1) JP2587711B2 (de)
AU (1) AU644877B2 (de)
DE (1) DE69130099T2 (de)
DK (1) DK0482213T3 (de)
ES (1) ES2121782T3 (de)
WO (1) WO1991016916A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818834B2 (ja) * 1991-08-12 1998-10-30 大塚製薬株式会社 ＩＬ−１α安定化医薬製剤
CN102209552A (zh) 2008-11-07 2011-10-05 联合技术Ut股份公司 含有白介素-1和肽的组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5995220A (ja) * 1982-11-22 1984-06-01 Ajinomoto Co Inc 免疫療法剤
EP0149551A3 (de) * 1984-01-16 1987-09-23 Genentech, Inc. Synergistische Gamma-Interferon-Interleukin-2-Zusammensetzungen und Verfahren zur Herstellung desselben
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
JPS61277628A (ja) * 1985-06-04 1986-12-08 Asahi Chem Ind Co Ltd 癌治療用白血球刺激材
JPS61280432A (ja) * 1985-06-05 1986-12-11 Asahi Chem Ind Co Ltd 抗腫瘍免疫細胞誘導方法
JPS62265233A (ja) * 1986-04-03 1987-11-18 シタス　コ−ポレイシヨン インタ−フエロン−β及びインタ−ロイキン−２を含有する医薬組成物

Also Published As

Publication number Publication date
AU644877B2 (en) 1993-12-23
AU7757491A (en) 1991-11-27
EP0482213A4 (en) 1993-03-17
EP0482213A1 (de) 1992-04-29
ES2121782T3 (es) 1998-12-16
JP2587711B2 (ja) 1997-03-05
DE69130099D1 (de) 1998-10-08
EP0482213B1 (de) 1998-09-02
JPH0418033A (ja) 1992-01-22
WO1991016916A1 (en) 1991-11-14
DK0482213T3 (da) 1999-02-08

Similar Documents

Publication Publication Date Title
DE69116912D1 (de) Breitstreckanlage
MX9102473A (es) Agentes farmaceuticos.
DE69014498T2 (de) Hyposensibilisierende wirksame Substanz.
DE69123611T2 (de) Aktiver Filter
NO924929D0 (no) Farmasoeytisk aktive benzoquinazolinforbindelser
MA22220A1 (fr) Formulations gelifiees
DE69128760T2 (de) Antidiarrhoeika
FI930894A0 (fi) Form foer flotationsprodukter
FI910254A (fi) Oralt aktiva renininhibitorer.
FI931156A (fi) Antiproliferativa substituerade naftalenfoereningar
BR9106516A (pt) Formulacoes pesticidas
FI892336A (fi) Levitystela
NO910022D0 (no) Fungiside virkestoffkombinasjoner.
DK0511991T3 (da) Farmaceutisk formulering
DE3881198D1 (de) Antiviraler wirkstoff.
DE69130099T2 (de) Antineoplastischer wirkstoff
AT400278B (de) Pfahl
ATA197990A (de) Streuvorrichtung
FI932766A0 (fi) Pesticida foereningar
BR9106776A (pt) Formulacoes pesticidas
ATA216190A (de) Streuwagen
NO910425L (no) Overflateaktive blandinger.
KR910019312U (ko) 파종기
KR920001765U (ko) 트랙터용 로터리
SE8902951D0 (sv) Active tunnel design

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee